SiPhox Funding & Investors
SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests for disease safely and in a disposable point-of-care and at-home manner. SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
siphox.bioTotal Amount Raised: $32,800,000
SiPhox Funding Rounds
Series A
$17,000,000
Series A Investors
Overlap HoldingsShorewind CapitalIntel CapitalLongeVCAlumni Ventures GroupVishal RaoDuke Capital PartnersUmami CapitalKortex VenturesKhosla VenturesMetaplanet HoldingsSeed
$10,000,000
Seed Investors
Longevitytech.fundVituityBalaji SrinivasanMass. Manufacturing Innovation InitiativeY CombinatorPaul BuchheitBob LeeR-Squared VenturesKhosla VenturesMetaplanet HoldingsSeed
$5,800,000
Seed Investors
Bantam GroupEvan ChengY CombinatorKhosla VenturesMetaplanet Holdings
Funding info provided by Diffbot.